Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

4.6K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
4.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Herpesvirus-6A and -6B (HHV-6A and HHV-6B): The Role of Roseoloviruses in Neurological Dysfunction and the Mechanisms of Viral-Induced Epileptogenesis.

Viruses·2026
Same author

Nonlinear Bivariate Associations and Mononuclear Cell-Type-Specific Expression Level Differences in the STING Signalling Pathway.

Journal of cellular and molecular medicine·2026
Same author

Differential survival benefit of curative versus non-curative intent treatment in a real-world cohort with early and intermediate-stage hepatocellular carcinoma.

Hepatology communications·2026
Same author

Shaping the Future of Biomaterials through Contributions by Our Early Career Board Members.

ACS biomaterials science & engineering·2026
Same author

Elevating an invisible role: co-designing solutions to optimize medical office assistants in primary care.

BMC primary care·2026
Same author

Commentary on Journal of School Psychology Special Issue: Bayesian Statistics.

Journal of school psychology·2025
Same journal

CAR-T cell therapy for multiple myeloma: An update on the current state and future potential.

Best practice & research. Clinical haematology·2025
Same journal

Cancer vaccines in hematologic malignancy: A systematic review of the rational and evidence for clinical use.

Best practice & research. Clinical haematology·2025
Same journal

Immune therapy of haematological cancers.

Best practice & research. Clinical haematology·2025
Same journal

Advances in NK cell therapy for multiple myeloma.

Best practice & research. Clinical haematology·2025
Same journal

Adoptive cellular therapies in multiple myeloma.

Best practice & research. Clinical haematology·2025
Same journal

Bispecific T-cell engager therapy for multiple myeloma.

Best practice & research. Clinical haematology·2025
See all related articles

Related Experiment Video

Updated: May 22, 2025

Author Spotlight: Importance of Single Cell Sorting in Isolating Purified Populations of Mesenchymal Stem Cells
13:44

Author Spotlight: Importance of Single Cell Sorting in Isolating Purified Populations of Mesenchymal Stem Cells

Published on: November 10, 2023

1.8K

Analyte heterogeneity analysis as a possible potency parameter for MSC.

David Kaplan1, Eric Christian1, Sarah Planchon Pope2

  • 1CellPrint Biotechnology, LLC, United States.

Best Practice & Research. Clinical Haematology
|March 12, 2025
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem/stromal cells (MSC) show variable therapeutic effects due to preparation heterogeneity. Analyzing molecular expression in MSCs can clarify these inconsistencies and improve cell therapy outcomes.

Keywords:
Analyte expression heterogeneityCorrelationFlow cytometryMesenchymal stromal cellsMultiple sclerosis

More Related Videos

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Published on: December 24, 2015

12.2K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.8K

Related Experiment Videos

Last Updated: May 22, 2025

Author Spotlight: Importance of Single Cell Sorting in Isolating Purified Populations of Mesenchymal Stem Cells
13:44

Author Spotlight: Importance of Single Cell Sorting in Isolating Purified Populations of Mesenchymal Stem Cells

Published on: November 10, 2023

1.8K
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Published on: December 24, 2015

12.2K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.8K

Area of Science:

  • Cell biology
  • Immunology
  • Regenerative medicine

Background:

  • Mesenchymal stem/stromal cells (MSC) transplantation yields inconsistent clinical outcomes.
  • Heterogeneity within MSC preparations and unclear therapeutic mechanisms contribute to variable results.
  • Understanding MSC molecular profiles is crucial for optimizing cell-based therapies.

Purpose of the Study:

  • To analyze the expression levels of molecules hypothesized to mediate MSC function.
  • To investigate the heterogeneity of molecular expression within and among MSC preparations.
  • To identify novel molecular correlations within MSCs that may indicate functional integrity.

Main Methods:

  • Quantitative analysis of molecular expression in MSC preparations.
  • Assessment of inter- and intra-preparation variability in analyte expression.
  • Identification of co-expressed molecular signatures in MSCs.

Main Results:

  • Most assessed molecules showed consistent expression levels.
  • Several molecules exhibited significant heterogeneity within and between MSC preparations from multiple sclerosis patients.
  • A novel set of highly intercorrelated molecules was identified in MSCs, suggesting a conserved molecular organization.

Conclusions:

  • Molecular heterogeneity in MSC preparations may explain variable therapeutic efficacy.
  • The identified intercorrelated molecular group could represent a core component of MSC activity.
  • Precise molecular analysis of MSCs is essential for addressing therapeutic variability and elucidating mechanisms of action.